Skip to content

Organon OGN Change in AP

Change in AP at other companies

Pfizer logo
PfizerPFE
-$117.25M+54.2%
Amgen logo
AmgenAMGN
$571M+14.9%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
$2M-14.0%
AbbVie logo
AbbVieABBV
-$1.59B-129%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
-$124.58M-10.6%
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
-$21.4M-41.7%

Other financials

Income statement

See full
Revenue$1.5B-3.5%
Gross profit$783.0M-6.9%
Net income$146.0M+67.8%
EPS (diluted)$0.55+66.7%

Balance sheet

See full
Cash & equivalents$1.1B+104%
Total debt$8.6B-4.3%
Total equity$903.0M+66.6%
Total assets$13.0B-1.2%

Cash flow

See full
Operating cash flow$225.0M+200%
CapEx$37.0M+15.6%
Free cash flow$188.0M+337%

Valuation

See full
Market cap$3.53B-59.4%

Profitability

See full
Gross margin52.8%-4.4pp
Net margin8%-12.3pp
FCF margin11.1%-1.3pp

Returns & leverage

See full
Return on equity71.6%
Debt / equity9.5×-7.0×
Current ratio+0.3×

Where this comes from

Reported directly by Organon in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableTrade.

The official record: Organon’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organon's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organon's change in AP?
Organon (OGN) reported change in AP of $32M in Q1 2026.
How has Organon's change in AP changed year-over-year?
Organon's change in AP increased by 121.5% year-over-year, from -$149M to $32M.
What does change in AP mean?
Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.